Calculation of your study is finished. Please find your results below.

A study for a 60 year old woman who takes Xeljanz - from FDA reports

13,455 females aged 60 (±5) who take the same drug are studied. This is a personalized study for a 60 year old female patient who has Nausea. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.

On Feb, 10, 2019

13,455 females aged 60 (±5) who take Xeljanz are studied.

Number of reports submitted per year:

Xeljanz for a 60-year old woman.

Information of the patient in this study:

  • Age: 60
  • Gender: female
  • Conditions: Nausea
  • Drugs taken:
    • Xeljanz (tofacitinib citrate)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  1. Headache (pain in head)
  2. Diarrhea
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Dizziness
  5. Nausea and vomiting
  6. Cough
  7. Back pain
  8. Fever
  9. Abdominal discomfort
  10. Sinusitis (inflammation of sinus)
1 - 6 months:
  1. Drug ineffective
  2. Headache (pain in head)
  3. Pain
  4. Fatigue (feeling of tiredness)
  5. Diarrhea
  6. Joint pain
  7. Nasopharyngitis (inflammation of the nasopharynx)
  8. Urinary tract infection
  9. Cough
  10. Pain in extremity
6 - 12 months:
  1. Drug ineffective
  2. Joint pain
  3. Diarrhea
  4. Urinary tract infection
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Pain
  7. Fatigue (feeling of tiredness)
  8. Pain in extremity
  9. Headache (pain in head)
  10. Back pain
1 - 2 years:
  1. Drug ineffective
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Headache (pain in head)
  4. Joint pain
  5. Cough
  6. Urinary tract infection
  7. Pneumonia
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Pain
  10. The flu (the flu is caused by an influenza virus)
2 - 5 years:
  1. Drug ineffective
  2. Urinary tract infection
  3. Cough
  4. Joint pain
  5. Pain
  6. Fall
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Weight increased
  9. Diarrhea
  10. Nasopharyngitis (inflammation of the nasopharynx)
5 - 10 years:
  1. C-reactive protein abnormal
  2. Septic shock (shock due to blood infection)
  3. Arthropathy
  4. Synovitis (inflammation of the synovial membrane)
  5. Rashes (redness)
  6. Pain
  7. Red blood cell sedimentation rate abnormal
  8. Drug ineffective
  9. Fatigue (feeling of tiredness)
  10. Impaired healing
10+ years:
  1. Drug ineffective
not specified:
  1. Drug ineffective
  2. Pain
  3. Joint pain
  4. Headache (pain in head)
  5. Fatigue (feeling of tiredness)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Rashes (redness)
  8. Diarrhea
  9. Pain in extremity
  10. Joint swelling

Top conditions involved for these people *:

  1. Pain : 449 people, 3.34%
  2. High Blood Pressure : 343 people, 2.55%
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints): 256 people, 1.90%
  4. High Blood Cholesterol : 221 people, 1.64%
  5. Depression : 159 people, 1.18%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 143 people, 1.06%
  7. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 133 people, 0.99%
  8. Blood Pressure Management : 122 people, 0.91%
  9. Preventive Health Care : 122 people, 0.91%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 121 people, 0.90%

Top co-used drugs for these people *:

  1. Enbrel (2,059 people, 15.30%)
  2. Humira (1,285 people, 9.55%)
  3. Plaquenil (922 people, 6.85%)
  4. Orencia (878 people, 6.53%)
  5. Actemra (769 people, 5.72%)
  6. Arava (695 people, 5.17%)
  7. Methotrexate (578 people, 4.30%)
  8. Celebrex (449 people, 3.34%)
  9. Rituxan (448 people, 3.33%)
  10. Remicade (425 people, 3.16%)

* Some reports may have incomplete information.

You are not alone:

What are the drugs?

What are the conditions?

Related studies:

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...


Thank you!